Maple Capital Management Inc. Sells 1,020 Shares of Intuitive Surgical, Inc. $ISRG

Key Points

• Maple Capital Management Inc. reduced its stake in Intuitive Surgical by 2.6%, selling 1,020 shares, which now constitutes approximately 1.5% of its holdings.
• Significant institutional activity was noted with Nuveen LLC acquiring a new stake valued at over $1.7 billion, while GAMMA Investing LLC increased its holdings by 54,010.7% during the same quarter.
• Intuitive Surgical's recent quarterly earnings exceeded expectations, reporting $2.19 EPS and $2.44 billion in revenue, marking a 21.4% year-over-year revenue increase.

Maple Capital Management Inc. lowered its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 2.6% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 38,623 shares of the medical equipment provider's stock after selling 1,020 shares during the period. Intuitive Surgical accounts for approximately 1.5% of Maple Capital Management Inc.'s holdings, making the stock its 25th biggest holding. Maple Capital Management Inc.'s holdings in Intuitive Surgical were worth $19,129,000 as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in ISRG. Nuveen LLC bought a new stake in shares of Intuitive Surgical during the 1st quarter valued at $1,715,899,000. GAMMA Investing LLC boosted its holdings in shares of Intuitive Surgical by 54,010.7% during the 1st quarter. GAMMA Investing LLC now owns 3,028,576 shares of the medical equipment provider's stock valued at $14,999,630,000 after buying an additional 3,022,979 shares in the last quarter. Goldman Sachs Group Inc. boosted its holdings in shares of Intuitive Surgical by 26.1% during the 1st quarter. Goldman Sachs Group Inc. now owns 2,819,666 shares of the medical equipment provider's stock valued at $1,396,496,000 after buying an additional 584,375 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in shares of Intuitive Surgical by 20.1% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,393,951 shares of the medical equipment provider's stock valued at $1,680,922,000 after buying an additional 566,979 shares in the last quarter. Finally, Wellington Management Group LLP boosted its holdings in shares of Intuitive Surgical by 15.0% during the 1st quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider's stock valued at $1,732,975,000 after buying an additional 457,080 shares in the last quarter. Institutional investors own 83.64% of the company's stock.

Insiders Place Their Bets

In other Intuitive Surgical news, Director Amy L. Ladd sold 336 shares of the business's stock in a transaction dated Wednesday, September 3rd. The stock was sold at an average price of $470.11, for a total value of $157,956.96. Following the completion of the transaction, the director owned 1,074 shares of the company's stock, valued at approximately $504,898.14. The trade was a 23.83% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Gary S. Guthart sold 29,360 shares of the business's stock in a transaction dated Friday, August 29th. The stock was sold at an average price of $472.49, for a total value of $13,872,306.40. Following the completion of the transaction, the insider directly owned 19,827 shares of the company's stock, valued at approximately $9,368,059.23. This trade represents a 59.69% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 45,224 shares of company stock valued at $21,716,492. 0.70% of the stock is owned by insiders.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock opened at $455.85 on Friday. The stock has a market cap of $163.41 billion, a price-to-earnings ratio of 63.58, a PEG ratio of 4.72 and a beta of 1.61. The firm's 50-day moving average is $487.55 and its 200 day moving average is $509.57. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.93 by $0.26. The company had revenue of $2.44 billion for the quarter, compared to analysts' expectations of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. Intuitive Surgical's revenue was up 21.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.78 EPS. On average, equities analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Analyst Ratings Changes

A number of analysts have recently commented on the stock. Wells Fargo & Company boosted their target price on shares of Intuitive Surgical from $559.00 to $599.00 and gave the company an "overweight" rating in a report on Wednesday, July 23rd. Evercore ISI boosted their target price on shares of Intuitive Surgical from $470.00 to $550.00 and gave the company an "in-line" rating in a report on Tuesday, July 8th. UBS Group boosted their target price on shares of Intuitive Surgical from $547.00 to $585.00 and gave the company a "neutral" rating in a report on Wednesday, July 23rd. Royal Bank Of Canada restated an "outperform" rating and set a $615.00 target price on shares of Intuitive Surgical in a report on Tuesday, August 19th. Finally, Zacks Research cut shares of Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a report on Wednesday, August 20th. Thirteen investment analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $595.95.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.